Profile data is unavailable for this security.
About the company
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
- Revenue in USD (TTM)461.04m
- Net income in USD-54.66m
- Incorporated2019
- Employees825.00
- LocationOncology Institute Inc18000 Studebaker Rd, Suite 800CERRITOS 90703United StatesUSA
- Phone+1 (562) 735-3226
- Fax+1 (302) 636-5454
- Websitehttps://theoncologyinstitute.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Joint Corp | 39.73m | 3.07m | 129.04m | 443.00 | 41.97 | 5.80 | 26.28 | 3.25 | 0.2068 | -0.067 | 2.61 | 1.50 | 0.5333 | -- | 11.04 | 89,680.70 | 4.12 | 2.29 | 7.92 | 3.38 | 78.84 | 86.62 | 7.73 | 2.67 | -- | -- | 0.00 | 0.00 | 10.47 | 1.38 | 85.73 | -- | -19.39 | -- |
| Kindly MD Inc | 1.98m | -90.49m | 129.80m | 23.00 | -- | 0.264 | -- | 65.55 | -1.12 | -1.12 | 0.0357 | 1.12 | 0.0057 | -- | -- | 86,099.56 | -25.97 | -- | -37.58 | -- | 98.85 | -- | -4,569.49 | -- | -- | -- | 0.2983 | -- | -27.83 | -- | -123.66 | -- | -- | -- |
| Zomedica Corp | 29.45m | -84.52m | 132.29m | 152.00 | -- | 1.11 | -- | 4.49 | -0.0863 | -0.0863 | 0.0301 | 0.1221 | 0.1707 | 1.72 | 9.79 | 193,776.30 | -49.00 | -13.58 | -51.46 | -14.00 | 68.10 | -- | -286.96 | -177.17 | 7.02 | -- | 0.00 | -- | 8.33 | -- | -36.07 | -- | 58.14 | -- |
| Agilon Health Inc | 5.89bn | -322.90m | 149.66m | 1.08k | -- | 0.489 | -- | 0.0254 | -0.781 | -0.7455 | 14.24 | 0.7383 | 3.19 | -- | 5.08 | 5,469,862.00 | -17.51 | -15.06 | -62.18 | -26.41 | 0.5149 | 7.61 | -5.49 | -6.35 | -- | -- | 0.1025 | -- | 40.41 | 50.14 | -28.34 | -- | 60.26 | -- |
| Alps Group Inc | 0.00 | -2.02m | 155.19m | 2.00 | -- | -- | -- | -- | -0.5111 | -0.5111 | 0.00 | -3.06 | 0.00 | -- | -- | -- | -12.10 | -- | -23.19 | -- | -- | -- | -- | -- | -- | -7.00 | -- | -- | -- | -- | -174.11 | -- | -- | -- |
| Oncology Institute Inc | 461.04m | -54.66m | 246.94m | 825.00 | -- | -- | -- | 0.5356 | -0.643 | -0.643 | 5.37 | -0.1258 | 2.69 | 27.10 | 8.08 | 558,835.10 | -38.67 | -20.19 | -57.52 | -24.68 | 14.82 | 17.89 | -14.38 | -12.70 | 1.39 | -3.27 | 1.19 | -- | 21.33 | 20.41 | 21.91 | -- | 25.76 | -- |
| Burning Rock Biotech Ltd (ADR) | 78.07m | -17.55m | 313.53m | 674.00 | -- | 3.94 | -- | 4.02 | -1.68 | -1.68 | 7.32 | 7.39 | 0.6002 | 2.41 | 2.79 | 115,823.90 | -13.50 | -37.64 | -18.61 | -45.81 | 73.02 | 69.83 | -22.48 | -124.32 | 2.91 | -- | 0.0036 | -- | -4.02 | 6.21 | 46.97 | -- | -33.43 | -- |
| Viemed Healthcare Inc | 254.79m | 13.61m | 314.79m | 1.18k | 24.97 | 2.36 | 7.60 | 1.24 | 0.3316 | 0.3316 | 6.20 | 3.51 | 1.37 | 22.40 | 9.36 | 216,110.30 | 7.52 | 10.84 | 9.73 | 13.49 | 57.89 | 60.94 | 5.49 | 8.63 | 1.01 | 18.03 | 0.135 | 0.00 | 22.54 | 22.82 | 9.98 | 5.73 | 23.06 | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 4.21m | 4.28% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 3.48m | 3.53% |
| CenterBook Partners LPas of 31 Dec 2025 | 3.03m | 3.08% |
| Balyasny Asset Management LPas of 30 Sep 2025 | 2.52m | 2.56% |
| Kanen Wealth Management LLCas of 30 Sep 2025 | 1.84m | 1.87% |
| Geode Capital Management LLCas of 31 Dec 2025 | 1.57m | 1.60% |
| Wexford Capital LPas of 31 Dec 2025 | 1.53m | 1.56% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 1.35m | 1.37% |
| Millennium Management LLCas of 30 Sep 2025 | 951.00k | 0.97% |
| Jane Street Capital LLCas of 31 Dec 2025 | 803.32k | 0.82% |
